GC
ZBH icon

Gratry & Company’s Zimmer Biomet ZBH Stock Holding History

Gratry & Company’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,289
Closed -$289K – 90
2016
Q3 		$289K Buy
+2,289
New +$283K 0.23% 54

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Gratry & Company's ZBH Position: Q4 2016 in Review

Gratry & Company sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 2,289 shares — an estimated $289K sold.

Gratry & Company first reported a position in ZBH in Q3 2016 and held it in 1 quarter. The position peaked at $289K in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

  • Gratry & Company reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
  • Gratry & Company sold 2,289 Zimmer Biomet shares in Q4 2016, an estimated $289K.
  • Gratry & Company first reported a position in Zimmer Biomet in Q3 2016 and held it in 1 quarter.
  • Gratry & Company's Zimmer Biomet position peaked at $289K in Q3 2016.
  • 812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on Gratry & Company's 13F filing for Q4 2016, filed 14 Feb 2017.